TBIO
Undervalued by 2122.6% based on the discounted cash flow analysis.
Market cap | $532,752.00 |
---|---|
Enterprise Value | $13.10 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-29.52 |
Beta | 0.97 |
Outstanding Shares | 1,732,238 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.01 |
---|---|
PEG | 0.03 |
Price to Sales | 0.04 |
Price to Book Ratio | 0.15 |
Enterprise Value to Revenue | 0.97 |
Enterprise Value to EBIT | -0.46 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 1.24 |
Debt to Equity | 4.21 |
No data
No data